Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer

References

• AndreFGrunenwaldDPignonJPSurvival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsJ Clin Oncol200018162981298910944131
   PubMed Web of Science ®Google Scholar
• GopalRSDubeySRosenzweigKEACR Appropriateness Criteria® on induction and adjuvant therapy for stage N2 non-small-cell lung cancer: expert panel on radiation oncology-lungInt J Radiat Oncol Biol Phys201078496997420813465
   PubMed Web of Science ®Google Scholar
• UnoTSumiMKiharaAPostoperative radiotherapy for non-small-cell lung cancer: results of the 1999–2001 patterns of care study nationwide process survey in JapanLung Cancer200756335736217328990
   PubMed Web of Science ®Google Scholar
• WintonTLivingstonRJohnsonDVinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancerN Engl J Med2005352252589259715972865
   PubMed Web of Science ®Google Scholar
• ArriagadaRBergmanBDunantALe ChevalierTPignonJPVansteenkisteJCisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancerN Engl J Med2004350435136014736927
   PubMed Web of Science ®Google Scholar
• ArriagadaRAuperinABurdettSAdjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient dataLancet201037597221267127720338627
   PubMed Web of Science ®Google Scholar
• DouillardJYRosellRDe LenaMAdjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialLancet Oncol20067971972716945766
   PubMed Web of Science ®Google Scholar
• RuckdeschelJCCombined modality therapy of non-small cell lung cancerSemin Oncol19972444294399280223
   PubMed Web of Science ®Google Scholar
• RamnathNDillingTJHarrisLJTreatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest2013143Suppl 5e314Se340S23649445
   PubMed Web of Science ®Google Scholar
• SpoelstraFOSenanSLe PechouxCVariations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring studyInt J Radiat Oncol Biol Phys20107641106111319560881
   PubMed Web of Science ®Google Scholar
• KepkaLBujkoKBujkoMTarget volume for postoperative radiotherapy in non-small cell lung cancer: results from a prospective trialRadiother Oncol20131081616523791302
   PubMed Web of Science ®Google Scholar
• MilesEFKelseyCRKirkpatrickJPMarksLBEstimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trialsInt J Radiat Oncol Biol Phys20076841047105217507176
   PubMed Web of Science ®Google Scholar
• KelseyCRCloughRWMarksLBLocal recurrence following initial resection of NSCLC: salvage is possible with radiation therapyCancer J200612428328816925972
   PubMed Web of Science ®Google Scholar
• SaynakMHigginsonDSMorrisDEMarksLBCurrent status of postoperative radiation for non-small-cell lung cancerSemin Radiat Oncol201020319220020685582
   PubMed Web of Science ®Google Scholar
• DarlingGEAllenMSDeckerPARandomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 TrialJ Thorac Cardiovasc Surg2011141366267021335122
   PubMed Web of Science ®Google Scholar
• AllenMSDarlingGEPechetTTMorbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trialAnn Thorac Surg200681310131019 discussion 1019–102016488712
   PubMed Web of Science ®Google Scholar
• DarlingGEAllenMSDeckerPANumber of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trialChest201113951124112920829340
   PubMed Web of Science ®Google Scholar
• De LeynPLardinoisDVan SchilPEuropean trends in preoperative and intraoperative nodal staging: ESTS guidelinesJ Thorac Oncol20072435736117409811
   PubMed Web of Science ®Google Scholar
• RuschVWAsamuraHWatanabeHGirouxDJRami-PortaRGoldstrawPThe IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancerJ Thorac Oncol20094556857719357537
   PubMed Web of Science ®Google Scholar
• KelseyCRLightKLMarksLBPatterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumesInt J Radiat Oncol Biol Phys20066541097110516682136
   PubMed Web of Science ®Google Scholar
• QinPYuanZWangJResearch on Postoperative Radiotherapy for Non-small Cell Lung Cancer of Stage IIIA (N2) according to the Failure Patterns after Pulmonary ResectionZhongguo Fei Ai Za Zhi2009121010951100 Chinese20723349
   PubMedGoogle Scholar
• NarukeTSuemasuKIshikawaSLymph node mapping and curability at various levels of metastasis in resected lung cancerJ Thorac Cardiovasc Surg1978766832839713589
   PubMed Web of Science ®Google Scholar
• IchinoseYKatoHKoikeTOverall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trialsLung Cancer2001341293611557110
   PubMed Web of Science ®Google Scholar
• KiricutaICSelection and delineation of lymph node target volume for lung cancer conformal radiotherapy. Proposal for standardizing terminology based on surgical experienceStrahlenther Onkol2001177841042311544904
   PubMed Web of Science ®Google Scholar
• FengWFuXLCaiXWPatterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume designInt J Radiat Oncol Biol Phys20148851100110724529715
   PubMed Web of Science ®Google Scholar
• KepkaLBujkoKOrlowskiTMCardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapyRadiother Oncol201198223824320951453
   PubMed Web of Science ®Google Scholar
• KiricutaICMuellerGStiessJBohndorfWThe lymphatic pathways of non-small cell lung cancer and their implication in curative irradiation treatmentLung Cancer1994111–271828081706
   PubMed Web of Science ®Google Scholar
• GiraudPAntoineMLarrouyAEvaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planningInt J Radiat Oncol Biol Phys20004841015102411072158
   PubMed Web of Science ®Google Scholar
• YuanSMengXYuJDetermining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancerInt J Radiat Oncol Biol Phys200767372773417293231
   PubMed Web of Science ®Google Scholar
• WillersHStinchcombeTEBarrigerRBACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancerAm J Clin Oncol201538219720525803563
   PubMed Web of Science ®Google Scholar
• SocinskiMABlackstockAWBogartJARandomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105J Clin Oncol200826152457246318487565
   PubMed Web of Science ®Google Scholar
• OhIJKimKSKimYCA phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401Cancer Chemother Pharmacol20137261247125424091849
   PubMed Web of Science ®Google Scholar
• ScottiVMeattiniISaievaCPost-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patientsRadiother Oncol2010961848820541823
   PubMed Web of Science ®Google Scholar
• SlotmanBJLagerwaardFJSenanS4D imaging for target definition in stereotactic radiotherapy for lung cancerActa Oncol200645796697216982565
   PubMed Web of Science ®Google Scholar
• MachtayMLeeJHShragerJBKaiserLRGlatsteinERisk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinomaJ Clin Oncol200119193912391711579111
   PubMed Web of Science ®Google Scholar
• KrupitskayaYLooBWJrPost-operative radiation therapy (PORT) in completely resected non-small-cell lung cancerCurr Treat Options Oncol200894–634335619387842
   PubMed Web of Science ®Google Scholar
• Chinese Academy of Medical SciencesTo Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer (NCT00880971) Available from: https://clinicaltrials.gov/ct2/show/NCT00880971?term=To+Evaluate+Postoperative+3D+Conform+Radiotherapy+in+Patients+With+IIIA+%28N2%29+Non-small+Cell+Lung+Cancer.&rank=1. NLM identifier: NCT00880971 Accessed January 26, 2016
   Google Scholar
• SonettJRSuntharalingamMEdelmanMJPulmonary resection after curative intent radiotherapy (.59 Gy) and concurrent chemotherapy in non-small-cell lung cancerAnn Thorac Surg200478412001205 discussion 120615464470
   PubMed Web of Science ®Google Scholar
• SolimanMYarominaAAppoldSGTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trialRadiother Oncol2013106329930423333018
   PubMed Web of Science ®Google Scholar
• BaumannMHerrmannTKochRFinal results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)Radiother Oncol20111001768521757247
   PubMed Web of Science ®Google Scholar
• De RuysscherDFaivre-FinnCNestleUEuropean Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancerJ Clin Oncol201028365301531021079134
   PubMed Web of Science ®Google Scholar
• JacksonAMarksLBBentzenSMThe lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcomeInt J Radiat Oncol Biol Phys201076Suppl 3S155S16020171512
   PubMed Web of Science ®Google Scholar
• StewartLParmarMSouhamiRPostoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists GroupLancet199835291242572639690404
   PubMed Web of Science ®Google Scholar
• WakeleeHAStephensonPKellerSMPost-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590Lung Cancer200548338939715893008
   PubMed Web of Science ®Google Scholar
• BillietCDecaluweHPeetersSModern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysisRadiother Oncol201411013824100149
   PubMed Web of Science ®Google Scholar
• LallyBEZeltermanDColasantoJMHafftyBGDetterbeckFCWilsonLDPostoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results databaseJ Clin Oncol200624192998300616769986
   PubMed Web of Science ®Google Scholar
• ZouBXuYLiTA multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal diseaseInt J Radiat Oncol Biol Phys201077232132819775829
   PubMed Web of Science ®Google Scholar
• DaiHHuiZJiWPostoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institutionOncologist201116564165021482587
   PubMed Web of Science ®Google Scholar
• MantovaniCLevraNGFilippiARPostoperative radiotherapy for patients with completely resected pathologic n2 non-small-cell lung cancer: a retrospective analysisClin Lung Cancer201314219419922885347
   PubMed Web of Science ®Google Scholar
• PORT Meta-analysis Trialists GroupPostoperative radiotherapy for non-small cell lung cancerCochrane Database Syst Rev20052CD00214215846628
   PubMedGoogle Scholar
• BogartJAAronowitzJNLocalized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapyClin Cancer Res20051113 Pt 25004s5010s16000604
   PubMed Web of Science ®Google Scholar
• BonnerJATincherSAFiveashJBBalancing the possible effectiveness of postoperative radiotherapy for non-small-cell lung cancer against the possible detriment of radiation-induced toxicityJ Clin Oncol200119193905390711579109
   PubMed Web of Science ®Google Scholar
• DouillardJYRosellRDe LenaMRiggiMHurteloupPMaheMAImpact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) randomized trialInt J Radiat Oncol Biol Phys200872369570118439766
   PubMed Web of Science ®Google Scholar
• MikellJLGillespieTWHallWAPost-Operative Radiotherapy (PORT) is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data BaseJ Thorac Oncol201510346247125384064
   PubMed Web of Science ®Google Scholar
• RobinsonCGPatelAPBradleyJDPostoperative radiotherapy for pathologic n2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the national cancer data baseJ Clin Oncol201533887087625667283
   PubMed Web of Science ®Google Scholar
• KimBHKimHJWuHGRole of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysisClin Lung Cancer201415535636424996882
   PubMed Web of Science ®Google Scholar
• BradleyJDPaulusRGrahamMVPhase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group – RTOG 9705J Clin Oncol200523153480348715908657
   PubMed Web of Science ®Google Scholar
• BradleyJGrahamMVWinterKToxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinomaInt J Radiat Oncol Biol Phys200561231832815667949
   PubMed Web of Science ®Google Scholar
• KellerSMAdakSWagnerHA randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupN Engl J Med2000343171217122211071672
   PubMed Web of Science ®Google Scholar
• LallyBEDetterbeckFCGeigerAMThe risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the surveillance, epidemiology, and end results databaseCancer2007110491191717620279
   PubMed Web of Science ®Google Scholar
• von LievenHBurkhardtEPostoperative radiotherapy of NSCLC – outcome after 3-D treatment planningStrahlenther Onkol2001177630230611446319
   PubMed Web of Science ®Google Scholar
• HuiZDaiHLiangJSelection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapyThorac Cancer20156334635326273382
   PubMed Web of Science ®Google Scholar
• FerketichAKNilandJCMametRSmoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohortCancer2013119484785323023590
   PubMed Web of Science ®Google Scholar
• KogureYAndoMSakaHHistology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906LJ Thorac Oncol20138675375823575412
   PubMed Web of Science ®Google Scholar
• HanagiriTSugioKMizukamiMSignificance of smoking as a postoperative prognostic factor in patients with non-small cell lung cancerJ Thorac Oncol20083101127113218827608
   PubMed Web of Science ®Google Scholar
• NguyenSKMasson-CoteLFortinADagnaultAInfluence of smoking status on treatment outcomes after post-operative radiation therapy for non-small-cell lung cancerRadiother Oncol2010961899320541274
   PubMed Web of Science ®Google Scholar
• AsamuraHGoyaTKoshiishiYA Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancersJ Thorac Oncol200831465218166840
   PubMed Web of Science ®Google Scholar
• MorettiLYuDSChenHPrognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapyOncologist200914111106111519897534
   PubMed Web of Science ®Google Scholar
• MatsugumaHNakaharaRIshikawaYPostoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involvedInteract Cardiovasc Thorac Surg20087457357718413349
   PubMedGoogle Scholar
• WisniveskyJPHalmEABonomiMSmithCMhangoGBagiellaEPostoperative radiotherapy for elderly patients with stage III lung cancerCancer2012118184478448522331818
   PubMed Web of Science ®Google Scholar